ArticleEClinicalMedicine2024

Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measures, phase 2a clinical pilot trial.

Cuthbert Simpkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.